BNC Korea Co Ltd
KOSDAQ:256840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BNC Korea Co Ltd
Current Portion of Long-Term Debt
BNC Korea Co Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BNC Korea Co Ltd
KOSDAQ:256840
|
Current Portion of Long-Term Debt
₩946.4m
|
CAGR 3-Years
53%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Current Portion of Long-Term Debt
₩77B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Current Portion of Long-Term Debt
₩3.9B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Current Portion of Long-Term Debt
₩579.9m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Current Portion of Long-Term Debt
₩96.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Current Portion of Long-Term Debt
₩55.1B
|
CAGR 3-Years
262%
|
CAGR 5-Years
126%
|
CAGR 10-Years
N/A
|
|
BNC Korea Co Ltd
Glance View
BNC Korea Co., Ltd. researches and develops strategic application products which include medical devices, pharmaceuticals, and cosmetic products containing physiologically active substances by processing hyaluronic acid and collagen. The company is headquartered in Daegu, Daegu. The company went IPO on 2016-12-28. The firm's main products include hyaluronic acid (HA) fillers, collagen wound dressings, antiadhesion materials and collagen tissue supplements, and others. In addition, the Company produces and sells cosmetics, medicines and medical devices, among others.
See Also
What is BNC Korea Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
946.4m
KRW
Based on the financial report for Sep 30, 2025, BNC Korea Co Ltd's Current Portion of Long-Term Debt amounts to 946.4m KRW.
What is BNC Korea Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
18%
Over the last year, the Current Portion of Long-Term Debt growth was 109%. The average annual Current Portion of Long-Term Debt growth rates for BNC Korea Co Ltd have been 53% over the past three years , 18% over the past five years .
